tiprankstipranks
Trending News
More News >
Santen Pharmaceutical Co Ltd (SNPHF)
OTHER OTC:SNPHF
US Market

Santen Pharmaceutical Co (SNPHF) Cash flow

Compare
6 Followers

Santen Pharmaceutical Co Cash Flow

SNPHF's free cash flow for Q4 2025 was ¥17.96B. For the 2025 fiscal year, SNPHF's free cash flow was decreased by ¥-9.06B and operating cash flow was ¥18.89B. See a summary of the company’s cash flow.
Cash Flow
Mar 26Mar 25Mar 24Mar 23Mar 22
Operating Cash Flow
¥ 60.93B¥ 72.65B¥ 37.15B¥ 46.04B¥ 38.81B
Investing Cash Flow
¥ -8.22B¥ -6.14B¥ -26.78B¥ -35.17B¥ -53.35B
Financing Cash Flow
¥ -53.31B¥ -34.03B¥ -37.22B¥ 5.56B¥ -16.68B
End Cash Position
¥ 93.00B¥ 94.58B¥ 57.90B¥ 83.01B¥ 62.89B
Free Cash Flow
¥ 54.27B¥ 63.33B¥ 19.87B¥ 28.70B¥ 34.67B
Currency in JPY

Santen Pharmaceutical Co Cash Flow